It Pays to Go Against the Crowd
Small investors have an abysmal track record when they try to time the market. That applies to both stocks and commodities.
Dr. Paul Price
Paul’s first profession was dentistry. As student loans were paid down he was seduced by the stock market. In 1987, Paul made a full-time career change. Over the years he worked for Merrill Lynch, A.G. Edwards, Wheat First Securities and Ferris Baker Watts, Inc. He garnered enough success to semi-retire while continuing to share his decades of knowledge and experience by writing about the market. Dr. Price has been a featured speaker at The Money Show in New York City and The International Traders’ Expo in Las Vegas. Paul’s articles are published every business day on RealMoneyPro, a subscription service of TheStreet.
Recent Content By
It Pays to Go Against the Crowd
Small investors have an abysmal track record when they try to time the market. That applies to both stocks and commodities.
Paul Price: Maximum Media = Turning Points
Paul Price discusses oil prices and media coverage.
Paul Price: Maximum Media = Turning Points
Paul Price discusses oil prices and media coverage.
Paul Price: Everyone’s Investment Time Horizon Is Really the Same
No matter what you’ve been told, your financial plan covers exactly the same period that mine does. It is always, “The rest of your life.”
Paul Price: Everyone’s Investment Time Horizon Is Really the Same
No matter what you’ve been told, your financial plan covers exactly the same period that mine does. It is always, “The rest of your life.”
Paul Price: Contrary Thinkers Make More Money
Paul looks at the recent rout in oil and discusses some opportunities.
Paul Price: Contrary Thinkers Make More Money
Paul looks at the recent rout in oil and discusses some opportunities.
Paul Price: You Can’t Buy Past Performance
Funds that hold overpriced shares will be prone to underperformance going forward.
Paul Price: You Can’t Buy Past Performance
Funds that hold overpriced shares will be prone to underperformance going forward.
Paul Price: Trade Like an Insider
Nobody knows what a company is truly worth better than the people running the show.
Paul Price: Trade Like an Insider
Nobody knows what a company is truly worth better than the people running the show.
Paul Price: When Will the Fed Raise Rates? Never
Paul Price discusses if and when the Fed may raise rates.
Paul Price: When Will the Fed Raise Rates? Never
Paul Price discusses if and when the Fed may raise rates.
Paul Price: Don't Fear "Fear"
Even the most steadfast bulls tend to freeze, like a deer in the headlights, when extreme volatility reigns.
Paul Price: Don't Fear "Fear"
Even the most steadfast bulls tend to freeze, like a deer in the headlights, when extreme volatility reigns.
Paul Price: Doctors Make the Best Investors – Here’s Why
"Taking the temperature" of a stock can tell you if it’s running a fever, relatively normal or hypothermic, and likely to either heat up or die.
Paul Price: Doctors Make the Best Investors – Here’s Why
"Taking the temperature" of a stock can tell you if it’s running a fever, relatively normal or hypothermic, and likely to either heat up or die.
Paul Price: 20 Years of Outperformance (from a Fund You've Never Heard of)
Dr. Paul Price looks at Royce Micro-Cap Trust.
Paul Price: 20 Years of Outperformance (from a Fund You've Never Heard of)
Dr. Paul Price looks at Royce Micro-Cap Trust.
Sign up for Advisor Access
Receive email updates about best performers, news, CE accredited webcasts and more.
Popular Articles
1
Active Fixed Income Could Have Another Banner Year in 2025
Justin Kuepper
|
Fixed income has several tailwinds going into 2025, especially compared to equities. Learn...
2
Disruptive Tech Active ETFs: A Golden Opportunity or a Costly Gamble
Aaron Levitt
|
Innovation ETFs offer the potential for high returns by investing in disruptive technologies,...
3
Should You Adjust Your Social Security Expectations?
Justin Kuepper
|
Retirement planning may seem like a moving target, but if you're not adjusting...